Analytical Data
-
Gene name
C21orf33
- Application
-
Alternative Names
Protein GT335Protein KNP-I
-
Species
Human
-
Source
E. coli
-
Tag
N- GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P30042
-
Expression Region
43-268aa
-
Molecular Weight
50.9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C21orf33, located on chromosome 21, has garnered interest in the field of molecular biology due to its potential roles in various physiological and pathological processes. Initially identified as a gene of unknown function, C21orf33 has been associated with several conditions, including developmental disorders and cancer. Research indicates that C21orf33 may play a role in cellular signaling pathways, influencing cell proliferation and differentiation. The reconstitution of the C21orf33 protein allows for detailed studies of its structural and functional characteristics, facilitating the exploration of its interactions with other proteins and cellular components. Additionally, recombinant C21orf33 protein is valuable for investigating its expression patterns across different tissues, aiding in the understanding of its biological significance. Studies utilizing this protein have the potential to unveil new insights into its mechanisms of action and contributions to disease pathology, with implications for therapeutic developments targeting related disorders. As a result, C21orf33 recombinant protein research is a promising avenue not only for elucidating the protein's function but also for exploring its potential as a biomarker or therapeutic target in various diseases.
